A National Cancer Institute-designated Comprehensive Cancer Center

Make an appointment: 800-826-HOPE
Cancer Genetics Career Development Program (CGCDP) Bookmark and Share

Cancer Genetics Career Development Program (CGCDP)

Funding for this program is pending; and although we are not accepting applications at this time, we hope to resume soon.
 
We are proud of our program and of the fellows trained through the years. Most have gone on to continue their work and research in the field of cancer genetics with prestigious institutions across the country.
 
 
 
__________________________________________________________________________
 
The City of Hope NCI-designated Comprehensive Cancer Center is offering an innovative Cancer Genetics Career Development Program (CGCDP) providing interdisciplinary training focused on cancer genetics and cancer prevention control research. The Traineeship, which is a mentored faculty position with a very competitive salary, will be open to only three applicants per year.
 
Program Description
This rigorous two-year program melds broad-spectrum mentored didactic and research training with graduate coursework in clinical cancer genetics, oncology, biostatistics, epidemiology, research methodology, clinical training and a research project , which may be in basic science or translational and clinical investigation.

Areas of research include:
 
  • Clinical Trials in Cancer Prevention and High-Risk Surveillance
  • Population Genetics
  • Genetic Epidemiology and Carcinogenesis
  • Basic Molecular Genetics
  • Clinical and Behavioral Outcomes
  • Health Services Research
  • Biomedical Informatics
  • Medical Oncology and Therapeutics Research
  • Pharmacogenetics
  • Molecular Pathology
 
The program has the advantage of extensive clinical research resources through an established prospective Hereditary Cancer Registry and City of Hope’s Cancer Screening & Prevention Program (CSPP).

Trainees will be able to have mentors from multiple, complementary disciplines; mentorship will be tailored to each Trainee’s individual needs.

Program graduates will receive:
 
  • Master’s degree from University of Southern California
  • Specialty Program Certificate from City of Hope
  • Qualification for the NIH Loan Repayment Program
  • Possible future NCI research support opportunities
 
Who Should Apply
  • Physician candidates will have completed a fellowship in Oncology or Clinical Genetics specialties
  • Doctoral Nurse candidates will have had some experience in the fields of medical oncology or clinical genetics
  • Other Postdoctoral candidates including, social scientists and clinical psychologists, interested in pursuing psychosocial and behavioral outcomes research in the emerging fields of clinical cancer genetics and genomics, public health and epidemiology, or a related field candidates will have completed a fellowship in Oncology or Clinical Genetics specialties
 
Minorities and women are encouraged to apply.
 
Applicants must be U.S. citizens or permanent residents, as required by the NCI-funded training grant supporting this position.
 

Academic Requirements

Within City of Hope's Cancer Genetics Career Development Program (CGCDP), course work, seminars, workshops and lectures are designed to:
 
  • Broaden trainees' understanding of the full spectrum of cancer genetics, oncology and epidemiology
  • Reinforce fundamentals of applied clinical and research methodology
  • Establish a solid foundation for cross-disciplinary clinical and research activities
 
The primary mentor and the Executive Committee monitor trainees’ academic progress and fulfillment of required course work and special projects. The academic curriculum is comprised of new courses and lecture series tailored specifically for the CGCDP and formal collaboration with established City of Hope and University of Southern California educational programs. Trainees are also required to attend and complete coursework for each of the lecture series and seminars included in the  sample Weekly Traineeship Clinical and Academic Calendar .
 
Overall, the CGCDP provides for:
 
  • Eight hours of experiential training
  • Ten hours academic coursework
  • Four hours of interdisciplinary clinical conference work weekly, with protected time for research and interdisciplinary rotations
 
Trainees will have a minimum of 18 hours of direct research experience or training every week. Year two curriculum centers on completion of cancer prevention and control research projects and preparation of research proposals, advanced course work and thesis requirements for obtaining a Master's degree.
 
Curriculum Overview
The curricular components described below are developed specifically for CGCDP to address the unique need for integrated multidisciplinary knowledge and skills in cancer genetics. In addition to the inter- and cross-disciplinary didactic content of these materials, the curriculum incorporates practical, hands-on synthesis of newly acquired knowledge and skills, refinement of research design and implementation skills, and ensures genetics professionals are apprised of the most current developments in this rapidly evolving field. The following are the curriculum components:
 
  • Clinical Cancer Genetics Course
  • Cancer Genetics Working Group
  • Topics in Clinical Cancer Genetics
  • Methods in Cancer Genetics Epidemiology Research
  • Clinical Investigation Training Program
  • Interdisciplinary City of Hope Educational Activities
 

Research Requirements

City of Hope's Cancer Genetics Career Development Program (CGCDP) promotes a dynamic exchange of information and ideas and a strong team-oriented approach to cancer genetics research.

To fulfill their CGCDP research requirements, trainees must:
 
  • Choose a topic for research (with assistance of primary mentor) and select one or more cross-disciplinary mentors to assist in project design and implementation by week ten of the first traineeship year.
  • Develop a project outline and timeline for completion by the first academic quarter and research progress reports on a quarterly basis thereafter. These are reviewed by the primary and cross-disciplinary mentor(s) and Executive Committee to allow for direction and guidance in completion of the project.
  • Present work before a traineeship conference, held at completion of the first traineeship year.
  • Second-year Fulfillment Requirements for Physician Trainees: Complete a second year of traineeship focused on additional research experience and crystallization of career development plans in cancer prevention and control research.
  • As part of the thesis requirements, prepare a grant proposal (PHS398 format), with the preliminary results section generated through a research project conducted by the trainee with the guidance of the research mentor. Intramural peer review by thesis committee staff and/or extramural review as a proposal submitted to the NIH, such as the Cancer Prevention, Control and Population Sciences Career Development Award (K07).
  • Depending on the individual trainee's prior experience and accomplishments during the traineeship, they may be appropriate candidates for the NCI Transition Career Development Award (K22) as a bridge to independent research leadership posts. The Mentored Patient-Oriented Research Career Development Award (K23) is also a possible pathway for Trainees who show exceptional promise in clinical research.
  • All trainees can choose project mentors from a wealth of intra- and extra-mural researchers, all of whom have ample mentorship experience and funding to support the trainee.
  • Appropriately qualified trainees with more significant prior research experience may seek a research project grant (R01).
  • Additionally, second-year trainees will assume the role of Chief Trainee, providing continuity and peer mentorship for subsequent first-year trainees, which includes continued research activities for thesis development and coursework leading to Master’s degree qualification, as well as teaching duties and curriculum development.
 

City of Hope Training History

City of Hope’s faculty has provided postdoctoral training for more than 40 years. As an NCI-designated Comprehensive Cancer Center, City of Hope provides an organizational framework to stimulate interactive research between investigators, and shared facilities are developed to enhance innovative interdisciplinary research projects.

Basic programs within the City of Hope infrastructure include:
  • Molecular Biology
  • Molecular Carcinogenesis
  • Immunology
  • Virology and Gene Therapy
  • Hematological Malignancy Host and Environmental Determinants of Cancer Susceptibility
  • Clinical and Experimental Therapeutics
  • Clinical Cancer Genetics
 
Each of these programs is represented among the CGCDP faculty. This well-documented history of collaboration among scientists of different disciplines assures that CGCDP trainees will have multi-disciplinary didactic training and experience an integrated approach to clinical cancer genetics research.
 
Significance of NCCN Affiliation
City of Hope is a founding member of the National Comprehensive Cancer Network (NCCN), an alliance of 21 of the world's leading cancer centers located throughout the U.S. The goals of NCCN are to provide the highest quality of cancer care to the greatest number of patients, to advance the state of the art in cancer prevention, screening, diagnosis and treatment, and to enhance the effectiveness and efficiency of cancer care delivery.

City of Hope is one of five member institutions participating in a new NCCN project aimed at establishing a database of patients with a new diagnosis of breast cancer. The purpose is to evaluate outcomes and patterns of breast cancer care at member institutions.

The data center of the NCCN is housed in City of Hope’s Department of Information Sciences. At the clinical level, there are active Traineeship programs in Surgical Oncology, Medical Oncology and Hematology, and Hematopathology. The Department of Medical Oncology & Therapeutics Research and the Department of Hematology & Hematopoietic Cell Transplantation offer the joint Hematology-oncology Fellowship Program. This four-year program involves both didactic and “hands-on” experiences in biostatistics, clinical investigation, basic science and basic and translational research. The CGCDP utilizes key elements of this K12 curriculum.

In basic sciences, training is conducted in the areas of molecular biology, molecular genetics, protein chemistry, molecular immunology, virology and molecular pharmacology. There are currentlynearly 150 postdoctoral fellows in City of Hope laboratories.
 

Clinical Training Requirements

The Cancer Genetics Career Development Program (CGCDP) at City of Hope is structured to emphasize self-efficacy learning, with the Cancer Screening & Prevention Program Network (CSPPN) serving as the central arena for progressive, integrated clinical training. Each trainee will be required to participate in cancer risk assessment, counseling, testing, case management, and follow up for a minimum of four patients per calendar month (48 or more patients annually). Level of active participation in cases will be staged as follows:
  1. Initial period of case observation
  2. Increasing interaction and active participation during the session and in follow up activities
  3. Primary clinical involvement and full case responsibility
 
Trainee participation will be within a supervised setting with close mentorship at each level. Progression to full-level case responsibility will be determined on an individual basis through mentor-directed performance evaluations. Full case participation includes:
 
  • Pre-counseling case review
  • Entry of family and patient history data into Progeny database
  • Genetic counseling
  • Psychosocial assessment
  • Enrollment of candidate patients and families into the hereditary cancer registry protocol
  • Chemopreventive, epidemiological and behavioral research trials as appropriate
  • Participation in test results disclosure and risk management follow-up visits
  • Additional longitudinal case management
 
Trainees will be required to present each case seen at the weekly interdisciplinary Clinical Cancer Genetics (CCG) Working Group. Each trainee must also complete a case logbook comprised of a comprehensive summary of 25 cases and pass an oral exam related to three of these cases prior to completion of the program.

 

 

Program Training Plan and Curriculum

The traineeship is comprehensive in nature, and as such, combines rigorous academic requirements and research requirements with ample hands-on clinical training experience.

A working relationship between each Cancer Genetics Career Development Program (CGCDP) trainee and his or her primary mentor is established at the start of the training period. Trainees are funded for two years to allow for maturation of cancer prevention and control research projects and preparation of research proposals, advanced course work and thesis requirements for obtaining a Master’s degree. Continued research traineeship beyond the two-year period will be encouraged and is dependent upon successful competition for career development or independent research awards. TheAdvisory Committee will make recommendations for extension of traineeship and institutional commitment of appropriate space will be secured.

Training is centered on three main categories of integrated interdisciplinary and cross-disciplinary experience:

Academic : formal multidisciplinary course work, seminars and lectures
Experiential : mentored multi-site clinical training; participation in clinical case review conferences; enrollment and management of patients in the clinical setting
Mentored cross-disciplinary research project (core requirement): Cancer genetics is a new and evolving discipline wherein the research focus may be clinical (interventions/outcomes, behavioral), basic (genetic epidemiology, molecular biology), or translational
 

Cancer Genetics Career Development Program (CGCDP)

Cancer Genetics Career Development Program (CGCDP)

Funding for this program is pending; and although we are not accepting applications at this time, we hope to resume soon.
 
We are proud of our program and of the fellows trained through the years. Most have gone on to continue their work and research in the field of cancer genetics with prestigious institutions across the country.
 
 
 
__________________________________________________________________________
 
The City of Hope NCI-designated Comprehensive Cancer Center is offering an innovative Cancer Genetics Career Development Program (CGCDP) providing interdisciplinary training focused on cancer genetics and cancer prevention control research. The Traineeship, which is a mentored faculty position with a very competitive salary, will be open to only three applicants per year.
 
Program Description
This rigorous two-year program melds broad-spectrum mentored didactic and research training with graduate coursework in clinical cancer genetics, oncology, biostatistics, epidemiology, research methodology, clinical training and a research project , which may be in basic science or translational and clinical investigation.

Areas of research include:
 
  • Clinical Trials in Cancer Prevention and High-Risk Surveillance
  • Population Genetics
  • Genetic Epidemiology and Carcinogenesis
  • Basic Molecular Genetics
  • Clinical and Behavioral Outcomes
  • Health Services Research
  • Biomedical Informatics
  • Medical Oncology and Therapeutics Research
  • Pharmacogenetics
  • Molecular Pathology
 
The program has the advantage of extensive clinical research resources through an established prospective Hereditary Cancer Registry and City of Hope’s Cancer Screening & Prevention Program (CSPP).

Trainees will be able to have mentors from multiple, complementary disciplines; mentorship will be tailored to each Trainee’s individual needs.

Program graduates will receive:
 
  • Master’s degree from University of Southern California
  • Specialty Program Certificate from City of Hope
  • Qualification for the NIH Loan Repayment Program
  • Possible future NCI research support opportunities
 
Who Should Apply
  • Physician candidates will have completed a fellowship in Oncology or Clinical Genetics specialties
  • Doctoral Nurse candidates will have had some experience in the fields of medical oncology or clinical genetics
  • Other Postdoctoral candidates including, social scientists and clinical psychologists, interested in pursuing psychosocial and behavioral outcomes research in the emerging fields of clinical cancer genetics and genomics, public health and epidemiology, or a related field candidates will have completed a fellowship in Oncology or Clinical Genetics specialties
 
Minorities and women are encouraged to apply.
 
Applicants must be U.S. citizens or permanent residents, as required by the NCI-funded training grant supporting this position.
 

Academic Requirements

Academic Requirements

Within City of Hope's Cancer Genetics Career Development Program (CGCDP), course work, seminars, workshops and lectures are designed to:
 
  • Broaden trainees' understanding of the full spectrum of cancer genetics, oncology and epidemiology
  • Reinforce fundamentals of applied clinical and research methodology
  • Establish a solid foundation for cross-disciplinary clinical and research activities
 
The primary mentor and the Executive Committee monitor trainees’ academic progress and fulfillment of required course work and special projects. The academic curriculum is comprised of new courses and lecture series tailored specifically for the CGCDP and formal collaboration with established City of Hope and University of Southern California educational programs. Trainees are also required to attend and complete coursework for each of the lecture series and seminars included in the  sample Weekly Traineeship Clinical and Academic Calendar .
 
Overall, the CGCDP provides for:
 
  • Eight hours of experiential training
  • Ten hours academic coursework
  • Four hours of interdisciplinary clinical conference work weekly, with protected time for research and interdisciplinary rotations
 
Trainees will have a minimum of 18 hours of direct research experience or training every week. Year two curriculum centers on completion of cancer prevention and control research projects and preparation of research proposals, advanced course work and thesis requirements for obtaining a Master's degree.
 
Curriculum Overview
The curricular components described below are developed specifically for CGCDP to address the unique need for integrated multidisciplinary knowledge and skills in cancer genetics. In addition to the inter- and cross-disciplinary didactic content of these materials, the curriculum incorporates practical, hands-on synthesis of newly acquired knowledge and skills, refinement of research design and implementation skills, and ensures genetics professionals are apprised of the most current developments in this rapidly evolving field. The following are the curriculum components:
 
  • Clinical Cancer Genetics Course
  • Cancer Genetics Working Group
  • Topics in Clinical Cancer Genetics
  • Methods in Cancer Genetics Epidemiology Research
  • Clinical Investigation Training Program
  • Interdisciplinary City of Hope Educational Activities
 

Research Requirements

Research Requirements

City of Hope's Cancer Genetics Career Development Program (CGCDP) promotes a dynamic exchange of information and ideas and a strong team-oriented approach to cancer genetics research.

To fulfill their CGCDP research requirements, trainees must:
 
  • Choose a topic for research (with assistance of primary mentor) and select one or more cross-disciplinary mentors to assist in project design and implementation by week ten of the first traineeship year.
  • Develop a project outline and timeline for completion by the first academic quarter and research progress reports on a quarterly basis thereafter. These are reviewed by the primary and cross-disciplinary mentor(s) and Executive Committee to allow for direction and guidance in completion of the project.
  • Present work before a traineeship conference, held at completion of the first traineeship year.
  • Second-year Fulfillment Requirements for Physician Trainees: Complete a second year of traineeship focused on additional research experience and crystallization of career development plans in cancer prevention and control research.
  • As part of the thesis requirements, prepare a grant proposal (PHS398 format), with the preliminary results section generated through a research project conducted by the trainee with the guidance of the research mentor. Intramural peer review by thesis committee staff and/or extramural review as a proposal submitted to the NIH, such as the Cancer Prevention, Control and Population Sciences Career Development Award (K07).
  • Depending on the individual trainee's prior experience and accomplishments during the traineeship, they may be appropriate candidates for the NCI Transition Career Development Award (K22) as a bridge to independent research leadership posts. The Mentored Patient-Oriented Research Career Development Award (K23) is also a possible pathway for Trainees who show exceptional promise in clinical research.
  • All trainees can choose project mentors from a wealth of intra- and extra-mural researchers, all of whom have ample mentorship experience and funding to support the trainee.
  • Appropriately qualified trainees with more significant prior research experience may seek a research project grant (R01).
  • Additionally, second-year trainees will assume the role of Chief Trainee, providing continuity and peer mentorship for subsequent first-year trainees, which includes continued research activities for thesis development and coursework leading to Master’s degree qualification, as well as teaching duties and curriculum development.
 

City of Hope Training History

City of Hope Training History

City of Hope’s faculty has provided postdoctoral training for more than 40 years. As an NCI-designated Comprehensive Cancer Center, City of Hope provides an organizational framework to stimulate interactive research between investigators, and shared facilities are developed to enhance innovative interdisciplinary research projects.

Basic programs within the City of Hope infrastructure include:
  • Molecular Biology
  • Molecular Carcinogenesis
  • Immunology
  • Virology and Gene Therapy
  • Hematological Malignancy Host and Environmental Determinants of Cancer Susceptibility
  • Clinical and Experimental Therapeutics
  • Clinical Cancer Genetics
 
Each of these programs is represented among the CGCDP faculty. This well-documented history of collaboration among scientists of different disciplines assures that CGCDP trainees will have multi-disciplinary didactic training and experience an integrated approach to clinical cancer genetics research.
 
Significance of NCCN Affiliation
City of Hope is a founding member of the National Comprehensive Cancer Network (NCCN), an alliance of 21 of the world's leading cancer centers located throughout the U.S. The goals of NCCN are to provide the highest quality of cancer care to the greatest number of patients, to advance the state of the art in cancer prevention, screening, diagnosis and treatment, and to enhance the effectiveness and efficiency of cancer care delivery.

City of Hope is one of five member institutions participating in a new NCCN project aimed at establishing a database of patients with a new diagnosis of breast cancer. The purpose is to evaluate outcomes and patterns of breast cancer care at member institutions.

The data center of the NCCN is housed in City of Hope’s Department of Information Sciences. At the clinical level, there are active Traineeship programs in Surgical Oncology, Medical Oncology and Hematology, and Hematopathology. The Department of Medical Oncology & Therapeutics Research and the Department of Hematology & Hematopoietic Cell Transplantation offer the joint Hematology-oncology Fellowship Program. This four-year program involves both didactic and “hands-on” experiences in biostatistics, clinical investigation, basic science and basic and translational research. The CGCDP utilizes key elements of this K12 curriculum.

In basic sciences, training is conducted in the areas of molecular biology, molecular genetics, protein chemistry, molecular immunology, virology and molecular pharmacology. There are currentlynearly 150 postdoctoral fellows in City of Hope laboratories.
 

Clinical Training Requirements

Clinical Training Requirements

The Cancer Genetics Career Development Program (CGCDP) at City of Hope is structured to emphasize self-efficacy learning, with the Cancer Screening & Prevention Program Network (CSPPN) serving as the central arena for progressive, integrated clinical training. Each trainee will be required to participate in cancer risk assessment, counseling, testing, case management, and follow up for a minimum of four patients per calendar month (48 or more patients annually). Level of active participation in cases will be staged as follows:
  1. Initial period of case observation
  2. Increasing interaction and active participation during the session and in follow up activities
  3. Primary clinical involvement and full case responsibility
 
Trainee participation will be within a supervised setting with close mentorship at each level. Progression to full-level case responsibility will be determined on an individual basis through mentor-directed performance evaluations. Full case participation includes:
 
  • Pre-counseling case review
  • Entry of family and patient history data into Progeny database
  • Genetic counseling
  • Psychosocial assessment
  • Enrollment of candidate patients and families into the hereditary cancer registry protocol
  • Chemopreventive, epidemiological and behavioral research trials as appropriate
  • Participation in test results disclosure and risk management follow-up visits
  • Additional longitudinal case management
 
Trainees will be required to present each case seen at the weekly interdisciplinary Clinical Cancer Genetics (CCG) Working Group. Each trainee must also complete a case logbook comprised of a comprehensive summary of 25 cases and pass an oral exam related to three of these cases prior to completion of the program.

 

 

Program Training Plan and Curriculum

Program Training Plan and Curriculum

The traineeship is comprehensive in nature, and as such, combines rigorous academic requirements and research requirements with ample hands-on clinical training experience.

A working relationship between each Cancer Genetics Career Development Program (CGCDP) trainee and his or her primary mentor is established at the start of the training period. Trainees are funded for two years to allow for maturation of cancer prevention and control research projects and preparation of research proposals, advanced course work and thesis requirements for obtaining a Master’s degree. Continued research traineeship beyond the two-year period will be encouraged and is dependent upon successful competition for career development or independent research awards. TheAdvisory Committee will make recommendations for extension of traineeship and institutional commitment of appropriate space will be secured.

Training is centered on three main categories of integrated interdisciplinary and cross-disciplinary experience:

Academic : formal multidisciplinary course work, seminars and lectures
Experiential : mentored multi-site clinical training; participation in clinical case review conferences; enrollment and management of patients in the clinical setting
Mentored cross-disciplinary research project (core requirement): Cancer genetics is a new and evolving discipline wherein the research focus may be clinical (interventions/outcomes, behavioral), basic (genetic epidemiology, molecular biology), or translational
 
Clinical Cancer Genetics
The City of Hope Division of Clinical Cancer Genetics is committed to being a national leader in the advancement of cancer genetics, screening and prevention, through innovative patient care, research and education.

Contact Us
  • 800-826-HOPE (4673)
  • For more information about the Cancer Screening & Prevention Program, call 626-256-8662, ext. 2.
Beckman Research Institute of City of Hope is internationally  recognized for its innovative biomedical research.
City of Hope is one of only 41 Comprehensive Cancer Centers in the country, the highest designation awarded by the National Cancer Institute to institutions that lead the way in cancer research, treatment, prevention and professional education.
Learn more about City of Hope's institutional distinctions, breakthrough innovations and collaborations.
City of Hope Breakthroughs
Get the latest in City of Hope's research, treatment and news you can use on our blog, Breakthroughs.
 
 
NEWS & UPDATES
  • Ryan Chavira was a senior in high school when she began feeling sluggish, fatigued and, well, “down.” Trips to the doctor ended in “you’re fine” pronouncements; blood tests results showed nothing of real concern. But Chavira’s grandmother had passed away from ovarian cancer when she was in eig...
  • Brain tumors are exceptionally difficult to treat. They can be removed surgically, but individual cancer cells may have already spread elsewhere in the brain and can escape the effects of both radiation and chemotherapy. To prevent tumors from recurring, doctors need a way to find and stop those invasive cancer...
  • Breast cancer risk is personal; breast cancer risk assessment should be, too. To that end, City of Hope researchers have developed a starting point to help women (and their doctors) with a family history of the disease begin that risk assessment process. The result is an iPhone app, called BRISK, for Breast Can...
  • When it comes to breast cancer, women aren’t limited to getting screened and, if diagnosed, making appropriate treatment choices. They can also take a proactive stance in the fight against breast cancer by understanding key risk factors and practicing lifestyle habits that can help reduce their own breast...
  • Cancers of the blood and immune system are considered to be among the most difficult-to-treat cancers. A world leader in the treatment of blood cancers, City of Hope is now launching an institute specifically focused on treating people with lymphoma, leukemia and myeloma, as well as other serious blood and bone...
  • Genetics, genes, genome, genetic risk … Such terms are becoming increasingly familiar to even nonresearchers as studies and information about the human make-up become more extensive and more critical. At City of Hope, these words have long been part of our vocabulary. Researchers and physicians are studyi...
  • Mammograms are currently the best method to detect breast cancer early, when it’s easier to treat and before it’s big enough to feel or cause symptoms. But recent mammogram screening guidelines may have left some women confused about when to undergo annual testing. Here Lusi Tumyan, M.D., chief of t...
  • Although chemotherapy can be effective in treating cancer, it can also exact a heavy toll on a patient’s health. One impressive alternative researchers have found is in the form of a vaccine. A type of immunotherapy, one part of the vaccine primes the body to react strongly against a tumor; the second part dire...
  • The breast cancer statistic is attention-getting: One in eight women will be diagnosed with breast cancer during her lifetime. That doesn’t mean that, if you’re one of eight women at a dinner table, one of you is fated to have breast cancer (read more on that breast cancer statistic), but it does mean that the ...
  • Rob Darakjian was diagnosed with acute lymphoblastic leukemia at just 19 years old. He began chemotherapy and was in and out of the hospital for four months. After his fourth round of treatment, he received a bone marrow transplantation from an anonymous donor. Today, he’s cancer free. In his first post, ...
  • Advanced age tops the list among breast cancer risk factor for women. Not far behind is family history and genetics. Two City of Hope researchers delving deep into these issues recently received important grants to advance their studies. Arti Hurria, M.D., director of the Cancer and Aging Research Program, and ...
  • City of Hope is extending the reach of its lifesaving mission well beyond U.S. borders. To that end, three distinguished City of Hope leaders visited China earlier this year to lay the foundation for the institution’s new International Medicine Program. The program is part of City of Hope’s strategi...
  • A hallmark of cancer is that it doesn’t always limit itself to a primary location. It spreads. Breast cancer and lung cancer in particular are prone to spread, or metastasize, to the brain. Often the brain metastasis isn’t discovered until years after the initial diagnosis, just when patients were beginning to ...
  • Blueberries, cinnamon, baikal scullcap, grape seed extract (and grape skin extract), mushrooms, barberry, pomegranates … all contain compounds with the potential to treat, or prevent, cancer. Scientists at City of Hope have found tantalizing evidence of this potential and are determined to explore it to t...
  • Most women who are treated for breast cancer with a mastectomy do not choose to undergo reconstructive surgery. The reasons for this, according to a recent JAMA Surgery study, vary. Nearly half say they do not want any additional surgery, while nearly 34 percent say breast cancer reconstruction simply isn’t imp...